1.首都医科大学附属北京中医医院,北京市东城区美术馆后街23号,100010
2.北京中医医院顺义医院
3.北京中医药大学
4.中国中医科学院广安门医院
liubaoli@bjzhongyi.com
收稿:2022-08-20,
修回:2022-12-08,
纸质出版:2023-04-17
移动端阅览
赵启涵,戴浩然,姜韩雪等.基于脏腑风湿论构建原发性膜性肾病态靶辨治体系[J].中医杂志,2023,64(08):774-778.
ZHAO Qihan,DAI Haoran,JIANG Hanxue,et al.Constructing the State-Target Differentiation and Treatment System of Primary Membranous Nephropathy based on the Theory of Zang-fu (脏腑) Organs Wind-damp[J].Journal of Traditional Chinese Medicine,2023,64(08):774-778.
赵启涵,戴浩然,姜韩雪等.基于脏腑风湿论构建原发性膜性肾病态靶辨治体系[J].中医杂志,2023,64(08):774-778. DOI: 10.13288/j.11-2166/r.2023.08.005.
ZHAO Qihan,DAI Haoran,JIANG Hanxue,et al.Constructing the State-Target Differentiation and Treatment System of Primary Membranous Nephropathy based on the Theory of Zang-fu (脏腑) Organs Wind-damp[J].Journal of Traditional Chinese Medicine,2023,64(08):774-778. DOI: 10.13288/j.11-2166/r.2023.08.005.
原发性膜性肾病是一种自身免疫性肾小球病,已成为成人肾病综合征最主要的病理类型,可归属中医学“水肿病”范畴。在脏腑风湿论和态靶辨治理论体系基础上,提出原发性膜性肾病从病机衍变上可分为“虚、伏、变、损”四个阶段,临床表现包含“虚、寒、湿、瘀、积、饮”六态。治疗上以麻黄附子汤合肾着汤为病靶主方,针对“免疫、病理、指标”三个内含靶标,根据六态灵活化裁,谨守“温阳化积,解表散寒”的治疗总则,构建原发性膜性肾病的态靶辨治体系。
Primary membranous nephropathy (PMN) is an autoimmune glomerular disease, which has become the main pathological condition of nephrotic syndrome in adults, and belongs to “edema” in traditional Chinese medicine. Based on the theories of
zang
-
fu
(脏腑) organs wind-damp, and state differentiation and target treatment, it is proposed that PMN can be divided into four stages according to the progression of the pathological mechanism, that is deficiency, latency, change, and depletion, and the six states of the clinical manifestations include deficiency, cold, damp, stasis, accumulation, and retention.
Mahuang Fuzi Decoction and Shenzhuo Decoction
(麻黄附子汤合肾着汤) is the main prescription targeting the disease. Aiming at the three contained targets of immunity, pathology, and indicators, the prescription should be flexibly modified based on the six states, and the principle of warming yang and removing accumulation, releasing the exterior and dissipating cold should be adhered to, in order to construct a state-target differentiation and treatment system for PMN.
HOXHA E , REINHARD L , STAHL R . Membranous nephropathy: new pathogenic mechanisms and their clinical implications [J]. Nat Rev Nephrol , 2022 , 18 ( 7 ): 466 - 478 .
刘宝利 , 钟逸斐 , 刘伟敬 , 等 . 中医药临床优势病种探讨:膜性肾病 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 16 ): 185 - 190 .
刘宝利 , 赵进喜 , 刘玉宁 , 等 . 论膜性肾病的中医概念与中医药治疗 [J]. 北京中医药 , 2019 , 38 ( 3 ): 195 - 199 .
杨映映 , 张海宇 , 沈仕伟 , 等 . 仝小林“脏腑风湿论”述要 [J]. 北京中医药 , 2018 , 37 ( 6 ): 519 - 524 .
王翼天 , 杨映映 , 李深 , 等 . 运用脏腑风湿理论探讨肾病综合征的治疗 [J]. 北京中医药 , 2018 , 37 ( 9 ): 861 - 864 .
仝小林 . 态靶医学:中医未来发展之路 [J]. 中国中西医结合杂志 , 2021 , 41 ( 1 ): 16 - 18 .
董立硕 , 李青伟 , 张莉莉 , 等 . 基于态靶辨治选方用药的思路与临床应用 [J]. 中医杂志 , 2023 , 64 ( 3 ): 250 - 254 .
RONCO P , DEBIEC H . Molecular pathogenesis of membranous nephropathy [J]. Annu Rev Pathol , 2020 , 15 : 287 - 313 . doi: 10.1146/annurev-pathol-020117-043811 http://dx.doi.org/10.1146/annurev-pathol-020117-043811 .
LIU W , GAO C , LIU Z , et al . Idiopathic membranous nephropathy: glomerular pathological pattern caused by extrarenal immunity activity [J]. Front Immunol , 2020 , 11 : 1846 . doi: 10.3389/fimmu.2020.01846 http://dx.doi.org/10.3389/fimmu.2020.01846 .
智宇星 , 李红梅 , 徐安龙 . 中西医学视角下对免疫的再认识:基于辨证论治和免疫态的讨论 [J]. 中医杂志 , 2022 , 63 ( 21 ): 2001 - 2008 .
LIU W , GAO C , DAI H , et al . Immunological pathoge-nesis of membranous nephropathy: focus on PLA2R1 and its role [J]. Front Immunol , 2019 , 10 : 1809 . doi: 10. 3389/fimmu.2019.01809 http://dx.doi.org/10.3389/fimmu.2019.01809 .
VAN DE LOGT AE , FRESQUET M , WETZELS JF , et al . The anti-PLA2R antibody in membranous nephro-pathy: what we know and what remains a decade after its discovery [J]. Kidney Int , 2019 , 96 ( 6 ): 1292 - 1302 .
ZOU H , LI Y , XU G . Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy [J]. BMC Nephrol , 2019 , 20 ( 1 ): 442 .
赵启涵 , 戴浩然 , 刘文斌 , 等 . 从阳虚癥积辨识特发性膜性肾病 [J]. 北京中医药 , 2021 , 40 ( 2 ): 110 - 113 .
DONG Z , DAI H , GAO Y , et al . Effect of Mahuang Fuzi and Shenzhuo decoction on idiopathic membranous nephropathy: a multicenter, nonrandomized, single-arm clinical trial [J]. Front Pharmacol , 2021 , 12 : 724744 . doi: 10.3389/fphar.2021.724744 http://dx.doi.org/10.3389/fphar.2021.724744 .
郑鑫 , 邓跃毅 . 特发性膜性肾病不同病理分期患者抑郁、焦虑状态研究 [J]. 天津中医药大学学报 , 2019 , 38 ( 6 ): 554 - 557 .
李世军 , 郭锦洲 , 左科 , 等 . 膜性肾病静脉血栓栓塞症的临床研究 [J]. 肾脏病与透析肾移植杂志 , 2012 , 21 ( 1 ): 29 - 34 .
JOURDE-CHICHE N , FAKHOURI F , DOU L , et al . Endothelium structure and function in kidney health and disease [J]. Nat Rev Nephrol , 2019 , 15 ( 2 ): 87 - 108 .
GAO Y , DAI H , ZHANG N , et al . The ameliorative effect of Mahuang Fuzi and Shenzhuo Decoction on membranous nephropathy of rodent model is associated with autophagy and wnt/beta-catenin pathway [J]. Front Pharmacol , 2022 , 13 : 820130 . doi: 10.3389/fphar. 2022. 820130 http://dx.doi.org/10.3389/fphar.2022.820130 .
0
浏览量
0
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号